These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2532290)

  • 1. Immune suppression of anti-DNA antibody production using anti-idiotypic antibody-neocarzinostatin conjugates.
    Sasaki T; Koide Y; Yoshigaga K
    Methods Enzymol; 1989; 178():422-32. PubMed ID: 2532290
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro manipulation of human anti-DNA antibody production by anti-idiotypic antibodies conjugated with neocarzinostatin.
    Sasaki T; Tamate E; Muryoi T; Takai O; Yoshinaga K
    J Immunol; 1989 Feb; 142(4):1159-65. PubMed ID: 2521660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective elimination of anti-DNA antibody-producing cells by antiidiotypic antibody conjugated with neocarzinostatin.
    Sasaki T; Muryoi T; Takai O; Tamate E; Ono Y; Koide Y; Ishida N; Yoshinaga K
    J Clin Invest; 1986 Apr; 77(4):1382-6. PubMed ID: 2937806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological activity of the antitumor protein neocarzinostatin coupled to a monoclonal antibody by N-succinimidyl 3-(2-pyridyldithio)-propionate.
    Jung G; Köhnlein W; Lüders G
    Biochem Biophys Res Commun; 1981 Jul; 101(2):599-606. PubMed ID: 6458289
    [No Abstract]   [Full Text] [Related]  

  • 5. Suppression of anti-DNA antibody synthesis in vitro by a cross-reactive antiidiotypic antibody.
    Epstein A; Greenberg M; Diamond B; Grayzel AI
    J Clin Invest; 1987 Mar; 79(3):997-1000. PubMed ID: 3493261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chromosome aberrations in human cultured lymphocytes induced by neocarzinostatin].
    Tsuda S; Okamoto Y; Nishida K; Maekawa T; Taniwaki M; Sonoda Y; Abe T; Takino T
    Nihon Ketsueki Gakkai Zasshi; 1984 Aug; 47(5):1190-3. PubMed ID: 6240184
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of recurrent idiotypes within the unrestricted anti-fluorescein immune response.
    Reinitz DM; Voss EW
    J Immunol; 1985 Nov; 135(5):3365-71. PubMed ID: 2413119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the clonal diversity of the B cell repertoires in adult mice that differ in the expression of cell surface IgD.
    Fultz MJ; Finkelman FD; Metcalf ES
    Eur J Immunol; 1987 Aug; 17(8):1137-43. PubMed ID: 3113979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of ligand-independent cap formation of mouse lymphocytes and Raji cells by neocarzinostatin.
    Yahara I; Iwashita S; Ebina T; Satake M; Ishida N
    Cancer Res; 1979 Nov; 39(11):4687-93. PubMed ID: 159125
    [No Abstract]   [Full Text] [Related]  

  • 10. Ultrastructural analysis of human plasmacytoma cells prepared on affinity beads after exposure to anti-idiotype antibodies.
    Renau-Piqueras J; Wetter O; Miragall F; Brandhorst D; Martinez-Ramon A
    Leuk Res; 1984; 8(3):491-500. PubMed ID: 6431200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of formycin nucleotides, intrinsic protein fluorescence, and fluorescein isothiocyanate-labeled enzymes for measurement of conformational states of Na+,K+-ATPase.
    Karlish SJ
    Methods Enzymol; 1988; 156():271-7. PubMed ID: 2835610
    [No Abstract]   [Full Text] [Related]  

  • 12. Standards for ANA and anti-DNA.
    Feltkamp TE
    Clin Rheumatol; 1990 Mar; 9(1 Suppl 1):74-8. PubMed ID: 2118438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An uptake of fluorescein isothiocyanate labeled neocarzinostatin into the cancer and normal cells.
    Sakamoto S; Maeda H; Ogata J
    Experientia; 1979 Sep; 35(9):1233-5. PubMed ID: 158538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased intratumor concentration of fluorescein-isothiocyanate-labeled neocarzinostatin in rats under angiotensin-induced hypertension.
    Abe I; Hori K; Saito S; Tanda S; Li YL; Suzuki M
    Jpn J Cancer Res; 1988 Jul; 79(7):874-9. PubMed ID: 2971639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a monoclonal rat anti-mouse Ig light chain (RAMOL-1) antibody reduces background binding in immunohistochemical and fluorescent antibody analysis.
    Brodin NT; Jansson B; Hedlund G; Sjögren HO
    J Histochem Cytochem; 1989 Jul; 37(7):1013-24. PubMed ID: 2499618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assay of an antitumor protein, neocarzinostatin, and its antibody by fluorescence polarization.
    Maeda H
    Clin Chem; 1978 Dec; 24(12):2139-44. PubMed ID: 152680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of NZB/NZW murine nephritis by administration of a syngeneic monoclonal antibody to DNA. Possible role of anti-idiotypic antibodies.
    Hahn BH; Ebling FM
    J Clin Invest; 1983 Jun; 71(6):1728-36. PubMed ID: 6223048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facilitated internalization of neocarzinostatin and its lipophilic polymer conjugate, SMANCS, into cytosol in acidic pH.
    Oda T; Sato F; Maeda H
    J Natl Cancer Inst; 1987 Dec; 79(6):1205-11. PubMed ID: 2961908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The production and radioimmunoassay application of monoclonal antibodies to fluorescein isothiocyanate (FITC).
    Micheel B; Jantscheff P; Böttger V; Scharte G; Kaiser G; Stolley P; Karawajew L
    J Immunol Methods; 1988 Jun; 111(1):89-94. PubMed ID: 3134489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neocarzinostatin (NCS).
    Ishida N; Ebina T
    Jpn J Antibiot; 1977 Dec; 30 Suppl():93-103. PubMed ID: 148519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.